vimarsana.com
  1. Home
  2. Live Updates
  3. Shveta Dighe - Breaking News

Latest Breaking News On - Shveta dighe - Page 1 : vimarsana.com

Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders

Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesShveta dighePrnewswire carisma therapeutics incCarisma therapeutics inc

Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders

/PRNewswire/ Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and.

United statesShveta digheCarisma therapeutics incPrnewswire carisma therapeutics inc

Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders

Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesShveta dighePrnewswire carisma therapeutics incCarisma therapeutics incTherapeutics announces adjournmentAnnual meeting

Carisma Therapeutics to Participate in the Jefferies Global Healthcare Conference

Carisma Therapeutics to Participate in the Jefferies Global Healthcare Conference
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesSteven kellyShveta digheCarisma therapeutics incPrnewswire carisma therapeutics incChief executive officerJefferies global healthcare conferenceInvestor eventsInvestor relations

Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte

/PRNewswire/ Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and.

United statesDavendra sohalShveta digheEugenep kennedyDrug administrationCarisma therapeutics incAmerican society of clinical oncologyCompany annual report on formUniversity of cincinnati cancer centerExchange commissionCarisma therapeuticsChief medical officerCincinnati cancerAmerican societyClinical oncologyPrivate securities litigation reform act

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.